BIG 5-13

Share This Post

Niraparib for patients with HER2-negative, germline BRCA mutation-positive, locally advanced or metastatic breast cancer

For more information please visit NCT01905592

More To Explore


TRANS-BIG TRANSBIG was an EU-funded consortium coordinated by the Breast International Group to promote collaboration in translational breast cancer research. Share this trial What TRANSBIG

Read More


DECRESCENDO BIG 19-02 De-Escalation of adjuvant ChemotheRapy in HER2-positive, EStrogen reCEptor-negative, Node-negative early breast cancer patients who achieved pathological complete response after neoadjuvant chemotherapy and Dual HER2 blOckade Share

Read More